Pharmafile Logo

SGD Pharma expands capacity of siliconised glass vials with the announcement of a new siliconisation line at its Center of Excellence for Type I glass in France

January 22, 2024 – Manufacturing and Packing – SGD Pharma, manufacturing and packaging

22 January 2023 — Paris La Défense, France — SGD Pharma, global market leader in moulded glass primary packaging solutions for the pharmaceutical industry, announces the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant. The company enhances its already extensive range of in-house services by internalising its glass siliconisation offer, further ensuring responsiveness, security of supply and improved flexibility of vial sizes.      

Glass vials are regularly used for pharmaceutical packaging, though there is a growing market need for primary packaging that is suited to more sensitive, aggressive and viscous drug products. The application of a micro-layer silicone-based internal coating to the container provides a protective barrier that minimises interaction between the drug product and the primary packaging, while preserving the integrity of sensitive therapeutic products. 

SGD Pharma’s treatment uses an optimised spraying process that provides uniform coverage of the vial surface, ensuring a higher performance of the internal silicone thin-layer. The process is executed with rigorous quality control under an ISO 8 clean room, in an ISO 15378 certified facility.

This new operation at SQLM is suitable for all glass types in vial sizes ranging from 3ml to 500ml in both clear and amber glass, at a high processing capacity. The treatment is ideal for a wide variety of market applications including: anti-infectives, parenteral nutrition, diagnostics, animal health and oncology to name a few.

More details on the new line at SQLM and the benefits of internal siliconisation will be showcased by SGD Pharma on its booth (B60&B62) at Pharmapack 2024.

About SGD Pharma     

SGD Pharma is a global producer of moulded and tubular glass for pharmaceutical primary packaging. Building on over a century of expertise, we provide exceptional quality packaging solutions dedicated to parenteral, oral and nasal for every therapeutic application. Our worldwide clients are supported by more than 90 agents and distributors and benefit from ongoing innovation at our five best-in-class ISO 15378 certified, GMP compliant manufacturing plants, giving a truly global supply chain infrastructure. For more information on SGD Pharma’s innovations, visit the SGD Pharma website: https://www.sgd-pharma.com

SGD Pharma
Immeuble Patio Défense 14 bis terrasse Bellini 92807 Puteaux Cedex